Literature DB >> 28619598

Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients.

Iacopo Fabiani1, Nicola Riccardo Pugliese2, Salvatore La Carrubba3, Lorenzo Conte2, Francesco Antonini-Canterin4, Paolo Colonna5, Frank Benedetto6, Enrico Calogero2, Valentina Barletta2, Scipione Carerj7, Simona Buralli8, Stefano Taddei8, Maria Francesca Romano9, Vitantonio Di Bello2.   

Abstract

We evaluated the prognostic impact of a complex remodeling classification (CRC) in asymptomatic patients with arterial hypertension (AH). We retrospectively included 749 hypertensive patients (female 325, 43.4% age 62 ± 11.3 years) in Stages A and B of heart failure. CRC was evaluated including indexed left ventricular mass, end-diastolic volume, and relative wall thickness. After 45-month follow-up, we considered a composite endpoint: total mortality, myocardial infarction, myocardial revascularization, cerebrovascular events, and acute pulmonary edema. Blood pressure was controlled in 265 patients (35.4%), 317 (42.3%) were in Grade 1 of AH, 123 (16.4%) in Grade 2, and 44 (5.9%) in Grade 3. Considering CRC, 292 patients (38%) presented normal/physiological hypertrophy, 102 (13.6%) concentric remodeling, 29 (3.9%) eccentric remodeling, 157 (21%) concentric hypertrophy, 11 (1.5%) mixed hypertrophy, 52 (6.9%) dilated hypertrophy, and 36 (4.8%) eccentric hypertrophy. We observed a total of 73 events (9.7%). Kaplan-Meier method demonstrated a significant different survival in CRC-derived classes (P < .001). Cox regression demonstrated CRC as independent predictor (P = .01), after adjusting for age, gender, diabetes mellitus, grade of hypertension, antihypertensive therapy, stable ischemic heart disease, obesity, systolic and diastolic dysfunction, and classic remodeling classification. In asymptomatic patients with AH, CRC is an independent predictor of poor outcome.
Copyright © 2017 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echocardiography; ejection fraction; hypertension; remodeling

Mesh:

Substances:

Year:  2017        PMID: 28619598     DOI: 10.1016/j.jash.2017.05.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  6 in total

1.  Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trial.

Authors:  Luca Faconti; Charlotte Elizabeth Mills; Virginia Govoni; Haotian Gu; Steven Morant; Benju Jiang; J Kennedy Cruickshank; Andrew James Webb
Journal:  Br J Clin Pharmacol       Date:  2018-11-13       Impact factor: 4.335

2.  β1-Adrenergic Receptor Contains Multiple IAk and IEk Binding Epitopes That Induce T Cell Responses with Varying Degrees of Autoimmune Myocarditis in A/J Mice.

Authors:  Rakesh H Basavalingappa; Chandirasegaran Massilamany; Bharathi Krishnan; Arunakumar Gangaplara; Rajkumar A Rajasekaran; Muhammad Z Afzal; Jean-Jack Riethoven; Jennifer L Strande; David Steffen; Jay Reddy
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

3.  Risk factors for asymptomatic echocardiographic abnormalities that predict symptomatic heart failure.

Authors:  Jennifer M Coller; Fei Fei Gong; Michele McGrady; Louise Shiel; Danny Liew; Simon Stewart; Alice J Owen; Henry Krum; Christopher M Reid; David L Prior; Duncan J Campbell
Journal:  ESC Heart Fail       Date:  2021-11-30

4.  Evaluating Impact of Pulse Pressure on Indexes of Myocardial Work by Speckle-Tracking Echocardiography in Normotensive, Prehypertensive and Newly Diagnosed Hypertensive Patients.

Authors:  Zheng Qin; Dawei Liu; Xiaojun You; Qin Duan; Yu Zhao
Journal:  Int J Gen Med       Date:  2022-02-22

5.  Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats.

Authors:  Rong-Hua Zheng; Xiao-Jie Bai; Wei-Wei Zhang; Jing Wang; Feng Bai; Cai-Ping Yan; Erskine A James; Himangshu S Bose; Ning-Ping Wang; Zhi-Qing Zhao
Journal:  Drug Des Devel Ther       Date:  2019-08-06       Impact factor: 4.162

Review 6.  Arterial Hypertension and Cardiopulmonary Function: The Value of a Combined Cardiopulmonary and Echocardiography Stress Test.

Authors:  Lavinia Del Punta; Nicolò De Biase; Nicola Riccardo Pugliese; Stefano Masi; Alessio Balletti; Francesco Filidei; Alessandra Pieroni; Silvia Armenia; Alessandro Mengozzi; Matteo Mazzola; Valerio Di Fiore; Frank Lloyd Dini; Javier Rosada; Agostino Virdis; Stefano Taddei
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.